Recurrent Adenocarcinoma of the Pancreas
1 clinical trials · Condition
◉ Watch Recurrent Adenocarcinoma of the Pancreas
| Record | Firm | Date |
|---|---|---|
| Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas (NCT02739633) | Samyang Biopharmaceuticals Corporation | 2016-04-01 |
Track Recurrent Adenocarcinoma of the Pancreas automatically
Every clearance here is in the API, with alerts when new ones post.